Investors pledge over $4 million to Ybrain’s wearable Alzheimer’s headband

Korean wearable technology start-up Ybrain will be able extend clinical trials of a headband designed to inhibit the progression of Alzheimer's disease having received $3.5 million (€2.7 million) in Series A funding.